LANDIS+GYR GROUP AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.5 CHF | +3.72% |
|
+4.47% | -4.61% |
| Mar. 22 | Skin care company Galderma's shares open higher on stock market debut | RE |
| Feb. 14 | MJM Electric Cooperative Begins Deployment of Landis+Gyr's Gridstream Connect Cellular AMI Meters | CI |
Valuation
| Fiscal Period: März | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,867 | 2,011 | 1,919 | 1,833 | 2,205 | 2,315 | - | - |
| Enterprise Value (EV) 1 | 1,884 | 2,043 | 1,926 | 1,976 | 2,271 | 2,384 | 2,309 | 2,204 |
| P/E ratio | 15.2 x | 17.8 x | -4.95 x | 24.5 x | 10.4 x | 25.2 x | 18.8 x | 15.4 x |
| Yield | 4.89% | 4.61% | 3.12% | 3.43% | 3.22% | 3.18% | 3.39% | 3.58% |
| Capitalization / Revenue | 1.06 x | 1.18 x | 1.41 x | 1.25 x | 1.31 x | 1.2 x | 1.13 x | 1.08 x |
| EV / Revenue | 1.07 x | 1.2 x | 1.42 x | 1.35 x | 1.35 x | 1.23 x | 1.13 x | 1.03 x |
| EV / EBITDA | 7.92 x | 8.61 x | 13.8 x | 13.4 x | 16.2 x | 11 x | 9.09 x | 7.62 x |
| EV / FCF | 15.3 x | 17 x | 19.8 x | 22.3 x | -30.7 x | 32.9 x | 18.2 x | 13.3 x |
| FCF Yield | 6.56% | 5.89% | 5.06% | 4.49% | -3.26% | 3.04% | 5.5% | 7.53% |
| Price to Book | 1.02 x | 1.11 x | 1.41 x | 1.32 x | 1.46 x | 1.5 x | 1.45 x | 1.39 x |
| Nbr of stocks (in thousands) | 29,505 | 29,038 | 28,481 | 28,831 | 28,839 | 28,883 | - | - |
| Reference price 2 | 63.27 | 69.24 | 67.37 | 63.57 | 76.47 | 80.14 | 80.14 | 80.14 |
| Announcement Date | 5/6/19 | 5/6/20 | 5/5/21 | 5/5/22 | 5/2/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: März | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,765 | 1,699 | 1,357 | 1,464 | 1,681 | 1,936 | 2,041 | 2,149 |
| EBITDA 1 | 237.9 | 237.2 | 139.6 | 147 | 139.9 | 215.8 | 254.2 | 289.1 |
| EBIT 1 | 145.1 | 150.9 | -365.1 | 88.77 | 51.04 | 170.7 | 188.6 | 219.4 |
| Operating Margin | 8.22% | 8.88% | -26.9% | 6.06% | 3.04% | 8.82% | 9.24% | 10.21% |
| Earnings before Tax (EBT) 1 | 169 | 138.4 | -368.6 | 92.03 | 58.28 | 127.4 | 164.1 | 196.3 |
| Net income 1 | 122.2 | 113.7 | -392.4 | 79.4 | 207.9 | 93.67 | 125.6 | 150.8 |
| Net margin | 6.92% | 6.69% | -28.91% | 5.42% | 12.37% | 4.84% | 6.15% | 7.02% |
| EPS 2 | 4.150 | 3.900 | -13.61 | 2.590 | 7.320 | 3.182 | 4.273 | 5.201 |
| Free Cash Flow 1 | 123.5 | 120.4 | 97.34 | 88.69 | -74.07 | 72.44 | 127.1 | 166 |
| FCF margin | 7% | 7.09% | 7.17% | 6.06% | -4.41% | 3.74% | 6.23% | 7.73% |
| FCF Conversion (EBITDA) | 51.91% | 50.76% | 69.73% | 60.33% | - | 33.57% | 50% | 57.42% |
| FCF Conversion (Net income) | 101.06% | 105.9% | - | 111.7% | - | 77.33% | 101.16% | 110.08% |
| Dividend per Share 2 | 3.093 | 3.194 | 2.100 | 2.178 | 2.461 | 2.545 | 2.716 | 2.865 |
| Announcement Date | 5/6/19 | 5/6/20 | 5/5/21 | 5/5/22 | 5/2/23 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 862.8 | 836.2 | 623.5 | 733.9 | 700.9 | 763.1 | 728.7 | 952.7 | 970.5 | 955.8 |
| EBITDA 1 | 124.9 | 112.3 | 50.1 | 89.5 | 70.8 | 76.2 | 48.7 | 91.2 | 108.1 | 103 |
| EBIT 1 | 84.9 | 66 | -9.9 | -355.2 | 46.28 | 42.49 | 10.54 | 40.49 | 64.18 | 53.9 |
| Operating Margin | 9.84% | 7.89% | -1.59% | -48.4% | 6.6% | 5.57% | 1.45% | 4.25% | 6.61% | 5.64% |
| Earnings before Tax (EBT) | - | 50.41 | -12.77 | -355.8 | 48.65 | - | 28.89 | - | - | - |
| Net income 1 | 71.8 | 41.9 | -2 | -390.4 | 35 | - | 186.5 | - | 41.24 | 45.7 |
| Net margin | 8.32% | 5.01% | -0.32% | -53.2% | 4.99% | - | 25.59% | - | 4.25% | 4.78% |
| EPS 2 | 2.450 | 1.450 | -0.0700 | -13.54 | 1.210 | 1.380 | 6.570 | 0.7500 | 1.430 | 1.180 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 10/29/19 | 5/6/20 | 10/12/20 | 5/5/21 | 10/28/21 | 5/5/22 | 10/27/22 | 5/2/23 | 10/25/23 | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 17.2 | 32.8 | 6.9 | 144 | 65.6 | 68.9 | - | - |
| Net Cash position 1 | - | - | - | - | - | - | 5.44 | 111 |
| Leverage (Debt/EBITDA) | 0.0723 x | 0.1382 x | 0.0494 x | 0.9769 x | 0.4689 x | 0.3194 x | - | - |
| Free Cash Flow 1 | 124 | 120 | 97.3 | 88.7 | -74.1 | 72.4 | 127 | 166 |
| ROE (net income / shareholders' equity) | 6.72% | 6.84% | 0.23% | 5.76% | 14.3% | 7.27% | 8.44% | 9.22% |
| ROA (Net income/ Total Assets) | 4.79% | 4.65% | 0.15% | 3.57% | 8.83% | 4.7% | 5.53% | 5.92% |
| Assets 1 | 2,551 | 2,447 | -269,431 | 2,224 | 2,356 | 1,993 | 2,271 | 2,546 |
| Book Value Per Share 2 | 62.10 | 62.30 | 47.70 | 48.00 | 52.50 | 53.50 | 55.20 | 57.60 |
| Cash Flow per Share | - | - | 4.300 | 4.020 | -1.580 | - | - | - |
| Capex 1 | 40.5 | 28.5 | 26.6 | 27.1 | 28.3 | 33.6 | 32 | 33.4 |
| Capex / Sales | 2.29% | 1.68% | 1.96% | 1.85% | 1.68% | 1.73% | 1.57% | 1.55% |
| Announcement Date | 5/6/19 | 5/6/20 | 5/5/21 | 5/5/22 | 5/2/23 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
80.14
USD
Average target price
91.24
USD
Spread / Average Target
+13.85%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.61% | 2.31B | |
| +4.53% | 150B | |
| +18.99% | 130B | |
| +33.09% | 128B | |
| +9.46% | 60.91B | |
| +1.01% | 38.51B | |
| +93.59% | 34.82B | |
| +5.04% | 32.09B | |
| -11.73% | 31.4B | |
| +1.32% | 26.85B |
- Stock Market
- Equities
- LAND Stock
- Financials Landis+Gyr Group AG
